ArticleMolecular medicine (Cambridge, Mass.)2025

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome.

Zhuo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.